HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Therapeutic efficacy of n-Docosanol against velogenic Newcastle disease virus infection in domestic chickens.

AbstractIntroduction:
The control of Newcastle disease virus (NDV) infection depends solely on vaccination which in most cases is not sufficient to restrain the consequences of such a highly evolving viral disease. Finding out substances for preparing an efficient anti-ND drug would be of high value. n-Docosanol is a saturated fatty alcohol with an inhibitory effect against many enveloped viruses. In this study, we evaluated the therapeutic effect of n-docosanol on NDV infection and shedding in chickens.
Methods:
Chickens infected with a highly virulent NDV were treated with low to high concentrations of n-docosanol (20, 40, and 60 mg/kg body weight) for 4-successive days, once they showed the disease symptoms. Survival and curative rates, virus load, histopathological scoring, and virus shedding were defined.
Results:
Symptoms development was found to discontinue 24-72 hours post-treatment. Survival rate in the NDV-infected chickens raised 37.4-53.2% after the treatment. n-Docosanol treatment was also found to significantly reduce virus load in the digestive (26.2-33.9%), respiratory (38.3-63%), nervous (26.7-51.1%), and lymphatic (16.4-29.1%) tissues. Histopathological scoring of NDV lesions revealed prominent rescue effects on the histology of different tissues. Importantly, n-docosanol treatment significantly reduced virus shedding in oropharyngeal discharge and feces thereby allowing the restriction of NDV spread.
Conclusion:
Our findings suggest n-docosanol as a promising remedy in the control strategy of Newcastle disease in the poultry industry.
AuthorsAhmed Orabi, Ashraf Hussein, Ayman A Saleh, Ayman M Megahed, Mohamed Metwally, Hassan Moeini, Aya Sh Metwally
JournalFrontiers in microbiology (Front Microbiol) Vol. 13 Pg. 1049037 ( 2022) ISSN: 1664-302X [Print] Switzerland
PMID36483200 (Publication Type: Journal Article)
CopyrightCopyright © 2022 Orabi, Hussein, Saleh, Megahed, Metwally, Moeini and Metwally.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: